Document is current
Any future updates will be listed below
-
Authors
Botson, John K. https://orcid.org/0000-0002-9552-3351
Baraf, Herbert S. B.
Keenan, Robert T.
Albert, John
Masri, Karim R.
Peterson, Jeff
Yung, Christianne
Freyne, Brigid
Amin, Mona
Abdellatif, Abdul
Soloman, Nehad
Edwards, N. Lawrence
Strand, Vibeke
- License Information
-
More Information
Article History
Accepted: 6 December 2021
First Online: 15 February 2022
Compliance with Ethics Standards
:
: Dr. Botson has received research support from Horizon Therapeutics and Allena Pharmaceuticals as a principal investigator. He has received consulting/speaker fees from Horizon Therapeutics. He has participated on a Data Safety Monitoring Board/Advisory Board for Horizon Therapeutics.Dr. Baraf has received consulting/speaker fees from Horizon Therapeutics, and research grants or support from Horizon Therapeutics as an investigator.Dr. Keenan has been or is a consultant with Horizon Therapeutics, Arthrosi Therapeutics, Selecta Biosciences, Atom Biosciences, and Sobi Pharma. He has received honoraria/speaker fees from Horizon Therapeutics.Dr. Albert serves on a speaker bureau for Horizon Therapeutics. He has received consulting/speaker fees from Horizon Therapeutics. He has received travel support from Horizon Therapeutics. He has participated on an advisory board for Horizon Therapeutics.Dr. Masri has been or is a consultant with Guidepoint Global. He has received speaker fees/honoraria from Horizon Therapeutics, Eli Lilly, and Pfizer. He has received payment for expert testimony from Cantor & Associates. He has participated on an advisory board for Horizon Therapeutics. He owns stock/stock options in Horizon Therapeutics, Gilead, Corbus Pharmaceutical, and Aurinia Pharma.Dr. Peterson has received consulting/speaker fees from Horizon Therapeutics. He has participated on an advisory board for Horizon Therapeutics. He reports other financial/non-financial interests from Horizon Therapeutics.Dr. Yung has received consulting/speaker fees from Horizon Therapeutics. She has participated on an advisory board for Horizon Therapeutics.Dr. Freyne declares no conflict of interest.Dr. Amin has received speaker fees/honoraria from Horizon Therapeutics and Eli Lilly.Dr. Abdellatif has received consulting/speaker fees from Horizon Therapeutics. He has received payment for expert testimony from Horizon Therapeutics. He has participated on an advisory board for Horizon Therapeutics. He has received travel support from Horizon Therapeutics.Dr. Nehad Soloman serves on a speaker bureau for Horizon Therapeutics.Dr. N. Lawrence Edwards has received consulting fees from Horizon Therapeutics, Shanton Pharma, and Atom Biosciences and Pharmaceuticals. He has received payment for expert testimony from Takeda Pharmaceuticals.Dr. Strand reports consulting fees from AbbVie, Amgen, Arena, Aria, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, CORRONA, Crescendo/Myriad, EMD Serono, Equillium, Flexion, Galapagos, Genentech/Roche, Gilead, GSK, Horizon, Ichnos, Inmedix, Janssen, Kiniksa, Eli Lilly, Merck, MiMedx, Novartis, Pfizer, Regeneron, Rheos, R-Pharma, Samsung, Sandoz, Sanofi, Scipher, Servier, Setpoint, Sun Pharma, and UCB, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
